References
- Bagshaw M A. Radiotherapy of prostatic cancer: Stanford University experience. Prog Clin Biol Res 1984; 153: 493–512
- Bagshaw M A, Ray G R, Pestenma D A, et al. External beam radiation therapy of primary carcinoma of the prostate. Cancer 1975; 36: 723–728
- Beisland H O, Stranden E. Rectal temperature monitoring during Neodymium-YAG laser irradiation for prostatic carcinoma. Urol Res 1984; 12: 257–259
- Bridges C H, Belville W D, Insalco S J, Buck A S. Stage A prostatic carcinoma and repeat transurethral resection. A comparison 5 years later. J Urol 1983; 129: 307–308
- Byar D P, Mostofi F K, The V. A., Cooperative Urological Research Group. Carcinoma of the prostate— Prognostic evaluation of certain pathological features in 208 radical prostatectomies. Cancer 1972; 30: 5–13
- Fowler J E, Whitmore W F. The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer 1981; 47: 2941–2945
- Grossmann H B, Batata M, Hilaris B, Whitmore W F. 125I implantation for carcinoma of prostate. Urology 1982; 20: 591–598
- Guerriero W G, Carlton C E, Huggins P T. Combined interstitial and external radiotherapy in the definitive management of carcinoma of the prostate. Cancer 1980; 45: 1922–1928
- Halldórsson T. Biophysical fundamentals and instrumentation for the endovesical Nd-YAG laser application. Urologe A 1981; 20: 293–299
- Hanks G E, Leibel S, Kramer S. The dissemination of cancer by transurethral resection of locally advanced prostatic cancer. J Urol 1983; 129: 309–311
- Keiditsch E. Histological changes following endovesical Neodymium-YAG laser irradiation. Urologe A 1981; 20: 300–304
- Kronester A, Staehler G, Weinberg W, Keiditsch E. Risk of intestinal damage from endoscopic Neodymium-YAG laser irradiation of bladder tumors. Urologe A 1981; 20: 305–309
- Kurth K H, Altwein J E, Skoluda D, Hohenfellner R. Follow up of irradiated prostatic carcinoma by aspiration biopsy. J Urol 1977; 117: 615–617
- Leach G E, Cooper J F, Kagan A R, Snyder R, Forsythe A. Radiotherapy for prostatic carcinoma: Post-irradiation prostatic biopsy and recurrence patterns with long-term follow up. J Urol 1982; 128: 505–509
- Paulson D F, Lin G H, Hinshaw W, Stephani S. The Uro-Oncology Research Group. Radical surgery versus radiotherapy for adenocarcinoma for the prostate. Urol 1982; 128: 502–504
- Perez C A, Bauer W, Garza R, et al. Radiation therapy in the definitive treatment of localized carcinoma of the prostate. Cancer 1977; 40: 1425–1433
- Pilepich M V, Perez C A, Bauer W. Prognostic parameters in radiotherapeutic management of localized carcinoma of the prostate. J Urol 1980; 124: 485–487
- Sander S, Beisland H O. Laser in the treatment of localized prostatic cancer. J Urol 1984; 132: 280–281
- Sander S, Beisland H O, Fossberg E. Neodymium-YAG laser in the treatment of prostatic cancer. Urol Res 1982; 10: 85–86
- Tansey L A, Shanberg A M, Syed A MN, Puthawala A. Treatment of prostatic carcinoma by pelvic lymphadenectomy, temporary Iridium-192 implant and, external irradiation. Urology 1983; 21: 594–598
- Wilson C S, Dahl S D, Middleton R G. Pelvic lymphadenectomy for the staging of apparently localized prostatic cancer. J Urol 1977; 117: 197–198
- Zincke H, Farrow G M, Myers R P, Benson R C, Furlow W L, Utz D C. Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 1982; 128: 498–501